Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2L 3 pseudogene

Molecular classification: Pseudogene, Other

Overview

Ubiquitin-conjugating enzyme E2L 3 pseudogene (ENSG00000271621) is a pseudogene, meaning it is a DNA sequence derived from the gene encoding ubiquitin-conjugating enzyme E2L 3, but it is nonfunctional due to the accumulation of disabling mutations or loss of regulatory signals. It does not encode a functional protein and is not classified as an enzyme, receptor, or other typical therapeutic target. While some pseudogenes have been shown to participate in gene regulation through the production of RNA molecules, most—including this one—are not directly implicated in major biological pathways, disease mechanisms, or targeted by drugs.

Biological functions

Can act as a regulatory RNA element in some cases (rare for most pseudogenes), but no specific function assigned to this pseudogene

Disease associations

Other or none specifically known for this pseudogene; pseudogenes can occasionally play minor regulatory roles in cancer or other diseases but this is not established for ENSG00000271621

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2L 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2L 3 pseudogene.

Explore the full profile